For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
In the latest session, Actinium Pharmaceuticals Inc (AMEX: ATNM) closed at $1.63 up 3.82% from its previous closing price of $1.57. In other words, the price has increased by $3.82 from its previous closing price. On the day, 0.6 million shares were traded. ATNM stock price reached its highest trading level at $1.74 during the session, while it also had its lowest trading level at $1.6.
Ratios:
For a deeper understanding of Actinium Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.35 and its Current Ratio is at 9.35. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, B. Riley Securities on August 07, 2024, Downgraded its rating to Neutral and sets its target price to $2 from $16 previously.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $25.
On September 06, 2023, HSBC Securities started tracking the stock assigning a Buy rating and target price of $11.60.HSBC Securities initiated its Buy rating on September 06, 2023, with a $11.60 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATNM now has a Market Capitalization of 50849316 and an Enterprise Value of -13042698.
Stock Price History:
The Beta on a monthly basis for ATNM is -0.53, which has changed by -0.7358185 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, ATNM has reached a high of $7.16, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is 1.02%, while the 200-Day Moving Average is calculated to be 12.54%.
Shares Statistics:
For the past three months, ATNM has traded an average of 322.47K shares per day and 276080 over the past ten days. A total of 31.20M shares are outstanding, with a floating share count of 30.40M. Insiders hold about 2.54% of the company’s shares, while institutions hold 28.22% stake in the company. Shares short for ATNM as of 1752537600 were 1027930 with a Short Ratio of 3.19, compared to 1749772800 on 1434399. Therefore, it implies a Short% of Shares Outstanding of 1027930 and a Short% of Float of 3.3000000000000003.
Earnings Estimates
Investors are keenly observing as 4.0 analysts analyze and rate the current performance of Actinium Pharmaceuticals Inc (ATNM) in the stock market.The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.3 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.2 and -$1.64 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$0.77, with 3.0 analysts recommending between -$0.08 and -$1.13.
